Issue 6, 2017

Synthesis and structure revision of symplocin A

Abstract

Symplocin A, a linear peptide possessing N-terminal N,N-dimethylisoleucine, statine, and valic acid residues, has been synthesized for the first time employing our previously established ‘one-pot intramolecular tandem protocol’. Moreover, the stereochemistry of natural symplocin A was unambiguously revised through the confirmation by 1D NMR, 2D NMR, and HPLC comparisons with an authentic natural product.

Graphical abstract: Synthesis and structure revision of symplocin A

Supplementary files

Article information

Article type
Research Article
Submitted
19 Jan 2017
Accepted
06 Feb 2017
First published
09 Feb 2017

Org. Chem. Front., 2017,4, 995-1004

Synthesis and structure revision of symplocin A

L. Shao, C. Si, Z. Mao, W. Zhou, T. F. Molinski, B. Wei and G. Lin, Org. Chem. Front., 2017, 4, 995 DOI: 10.1039/C7QO00052A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements